Preferentially Expressed Antigen in Melanoma (PRAME) Peptid
PRAME
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle PRAME Produkte
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- MERRRLWGSI QSRYISMSVW TSPRRLVELA GQSLLKDEAL AIAALELLPR
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of PRAME antibody, catalog no. 70R-2630
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Synonyme
- PRAME Peptide, CT130 Peptide, MAPE Peptide, OIP-4 Peptide, OIP4 Peptide, 4930534P07Rik Peptide, preferentially expressed antigen in melanoma Peptide, PRAME Peptide, Prame Peptide
-
Sie sind hier:
